Latest filing published 02 Feb 2026 for Clover Health Investments, CORP. /de, €303k.
Peter J. Kuipers (finance chief) discloses dealings in 3 companies, chiefly Omnicell, Inc., Clover Health Investments, CORP. /de and Invacare Corp. The record holds 53 filings, for trades running from 4 February 2016 to 29 January 2026.
No open-market purchase appears, only 17 sales worth €4.3M. Other entries cover 27 share grants and 9 option exercises.
The latest filing, published on 2 February 2026, reports a share grant of €303k in Clover Health Investments, CORP. /de. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 53 declarations